HEDS Reference Set Application: Amit Singal, UTSW (2021) Prognostic Liver Secretome signature Validation
- Abbreviated Name
- HEDS Ref Set App: Singal (2021) PLSec
- Lead Investigator
- Singal, Amit — UT Southwestern Medical Center
- Coordinating Investigator
- Feng, Ziding — Fred Hutchinson Cancer Center
- Involved Investigators
Abstract
see objectives
Aims
To validate the performance of a blood-based molecular signature, Prognostic Liver Secretome signature (PLSec), to predict long-term risk of developing HCC in cirrhosis patients.
Analytic Method
Biomarker will be run blinded to clinical outcome
Outcome
Validate predictive biomarker for development of HCC in patients with cirrhosis
Publications
- No publications available at this time for this protocol.
Biomarkers
- No biomarkers available at this time for this protocol.
Data Collections
- No data collections available at this time for this protocol.
Team Project
- Start Date
- May 1 2021
- Estimated Finish Date
- Feb 1 2022
- Finish Date
- Nov 17 2021
- Protocol ID
- 493
- Protocol Type
- Reference Set
- Fields of Research
-
- Proteomics
- Collaborative Group
- G.I. and Other Associated Cancers Research Group
- Cancer Types
-
- Liver cell carcinoma